Background. Kaposi sarcoma (KS) may arise as a complication of kidney trans
plantation. In the Saint Luc Teaching Hospital in Brussels, patients of bot
h Belgian and foreign origin are treated. The prevalence of human herpes vi
rus 8 (HHV-8) infection differs in different geographical settings. We want
ed to estimate the background infection rate and the risk of infection in o
ur transplant population: a first step towards evaluating the necessity of
HHV-8 screening.
Methods. Serum samples were taken from 210 organ donors over a period of 7
years (30 per year) and from 200 kidney recipients from whom two sera were
tested, one pre-transplant and the second 6-12 months posttransplant, All s
era were screened for HHV-8 by an enzyme-linked immunosorbant assay using r
ecombinant ORF 65 and ORF 73 antigens and an immunofluorescence assay for t
he latent antigen. Reactive samples were confirmed by western blotting.
Results, Seven donors (3.3%) were positive for HHV-8 antibodies. Of 198 pre
-transplant sera available for evaluation, 15 were positive (7.6%). Posttra
nsplantation 18/199 (9%) were positive: four (2.1% of negatives) had a docu
mented seroconversion and one lost the antibodies. No patients developed KS
.
Conclusions, A substantial number of kidney transplant patients already had
antibodies to HHV-8 at the time of transplantation. A further 2.1% of sero
negative patients had seroconversion, which could have been acquired throug
h the transplanted organ (3.3% of donors were positive) or through transfus
ion.